Understanding how a key protein of the COVID-19 virus works to help develop antiviral treatments
Defining the Translocation Mechanisms of SARS-CoV-2 nsp13 Helicase to Aid in Antiviral Development
This study is looking at a specific protein in the COVID-19 virus that helps it multiply, and by understanding how this protein works, researchers hope to create new medicines that can better fight the virus and help patients, especially with new variants coming up.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma State University Stillwater NIH-funded |
| Lab location | 1 site (Stillwater, United States) |
| Project ID | NIH-10920405 on NIH RePORTER |
What this research studies
This research focuses on the nsp13 helicase protein of the SARS-CoV-2 virus, which plays a crucial role in the virus's ability to replicate. By using advanced techniques like protein crystallography and molecular dynamics simulations, the researchers aim to uncover how this protein interacts with RNA and ATP, which are essential for the virus's life cycle. The findings could lead to the development of new antiviral drugs that specifically target this protein, providing alternative treatment options for COVID-19. Patients may benefit from these advancements as they could lead to more effective therapies against the virus, especially in light of emerging variants.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by COVID-19 or those at high risk of severe disease due to the virus.
Not a fit: Patients who are not infected with or at risk for COVID-19 may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral treatments for COVID-19, potentially improving patient outcomes.
How similar studies have performed: Other research has shown promise in targeting viral proteins for antiviral development, indicating that this approach could be effective.
Where this research is happening
Stillwater, United States
- Oklahoma State University Stillwater — Stillwater, United States (Active)
Researchers
- Principal investigator: Mccullagh, Martin — Oklahoma State University Stillwater
- Study coordinator: Mccullagh, Martin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.